Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
Study NCT ID:
NCT02863718
Status:
COMPLETED
Last Update Posted:
2024-12-30
First Post:
2014-06-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ibrutinib in Previously Untreated Binet Stage a Chronic Lymphocytic Leukemia with Risk of Disease Progression
Sponsor:
German CLL Study Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CLL12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |